Source: DGNews | Posted 8 years ago
Remicade (Infliximab) Gains European Approval for Maintenance Dosing In Treatment of Fistulizing Crohn's Disease
Tags:
KENILWORTH, NJ -- October 23, 2003 -- Schering-Plough Corporation (NYSE: SGP) today announced that the European Commission has granted a European Union (EU) approval of Remicade



Comments